Jason Lofters

Chief Heme/Onc Fellow @The_BMC| Future Classical Hematologist| 🇯🇲| Former PGY4 Chief Resident @englewood_IM| MedEd enthusiast

[Mark Lewis, MD, FASCO @marklewismd]

RBC tracking from marrow to spleen

[William Aird @WilliamAird4]

Last week I caught myself reacting to a trainee’s presentation style.
Then I paused.

I was trained 40 years ago to listen a certain way.
Maybe what I was hearing wasn’t poor communication.
Maybe it was generational difference.

WHAT IRRITATES ME ON ROUNDS
https://t.co/nyhGkkTcJq

[ASH @ASH_hematology]

Interested in a mentor to guide your career in malignant #hematology? Apply for ASH’s new Mentorship Program, and grow your network! Deadline: Sept 26. Apply today! 🔗 https://t.co/QgTdWwsDWD

Interested in becoming a mentor? Sign up today: https://t.co/fZ2Q7rbLLz

[Jason Lofters @loftersja]

I’m thrilled to be a participant in the Classical Hematology Advancement Mentorship Program (CHAMP) by @ASH_hematology! Feeling grateful for this opportunity and I’m excited to grow, collaborate, and make an impact in classical hematology! #ASHCHAMP #Hematology 🩸

[ASH @ASH_hematology]

The future of classical hematology is in excellent hands.

Fellows in CHAMP and HFFTP recently gathered for retreats centered on learning, mentorship, and community.

Learn more about these ASH programs 👇
CHAMP: https://t.co/U1oFVqLl2a

HFFTP: https://t.co/vaG6iXRHHX

[Jason Lofters @loftersja]

I’m going to @HemOncFellows’s upcoming Space. Will you join too? https://t.co/vfGcJt3ytx

[Frontiers - Oncology @FrontOncology]

#1 Original Research Article: Reliability of #CellFreeDNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms

👨‍⚕️👩‍⚕️ Ip A et al

Read here 👉 https://t.co/OWNNRaW4X6

#HemOnc #CancerSequencing #Biomarkers

[Frontiers - Oncology @FrontOncology]

New research: Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms: Introduction

Cytogenetic analysis is important for stratifying patients with various neoplasms. We explored… https://t.co/TsUn95PP2F #oncology

[Juliann Allen, MD @julesinrheum1]

Englewood IM owning an entire wall #SHMConverge #englewood_im @loftersja @englewood_im

[Lena Makartian, MD @LenaMakartian]

With my amazing Chiefs! @loftersja @julesinrheum1 #SHMconference #IMresident @englewood_im

[Andrea Anampa-Guzmán (she/ella) @AndreaAnampaG]

Very excited to be part of this multicenter study looking at autoimmune diseases and lymphoma. This will be an oral presentation at #ASH21 on Dec 11th. See you there!

Link: https://t.co/6NEoICvTpy

#LymSM @ASH_hematology #HOFellows #HemOnc

[Blood Journals Portfolio @BloodPortfolio]

Beware the “other AML”: hepatic angiomyolipoma with extensive extramedullary hematopoiesis https://t.co/HwoMlDgMyb #AML

[JGIM Journal of General Internal Medicine @JournalGIM]

Hypertensive “Urgency” Is a Harmful Misnomer https://t.co/ew9y4ydvtu